4Cheng Luo,Markku Kallajoki,Rene Gross,Mika Mulari,Tamara Teros,Laura Ylinen,Marjaana M?kinen,Jukka Laine,Olli Simell. Cellular distribution and contribution of cyclooxygenase (COX)-2 to diabetogenesis in NOD mouse[J] 2002,Cell and Tissue Research(2):169～175
5J. C. Pickup,M. B. Mattock,G. D. Chusney,D. Burt. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X[J] 1997,Diabetologia(11):1286～1292
3Parving HH, Osterby M, Ritz E. Diabetic Nephropathy[A]. In: Brenner BM ed. The Kideny[M]. Ioth ed.Philadalphia: WBS aunders company, 2000.1731～1754.
4Tjandrawinata RR, Dahiya R, Hughes M. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells[J]. Br J Cancer, 1997, 75(8): 1111～1118.
5Curtis SP, Ng J, Yu Q, et al. Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trails[J]. Clin Ther, 2004, 26(1): 70～83.
6Sandhu GK, Heyneman CA. Nephrotoxic potential of selective cyclooxygenase-2 inhibitors[J]. Ann Pharmacother, 2004, 38(4): 700～704.
7Tomasoni S, Noris M, Zappela S, et al. Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis[J].J Am Soc Nephrol,1998, 9:1202～1212.
8Takano T, Cybulsky AV, Cupples WA, et al. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis[J]. J Pharmacol Exp Ther, 2003, 305(1): 240～249.
9Yang T, Singh I, Pham H, et al. Regulation of cyclooxygenase expression in the kidney by dietary salt intake[J]. Am J Physiol, 1998, 274:F481～F489.
10Knmhoff M, Jeck DM, Seyberth W, et al. Cyclooxgenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome[J]. Kidney Int, 2000, 58:2420～2424.
